After $105M funding round, ALX Oncology nabs FDA fast-track tag for cancer hopeful

After $105M funding round, ALX Oncology nabs FDA fast-track tag for cancer hopeful

Submitted by admin on February 18, 2020 - 10:55am
Source: 
Fierce Biotech
News Tags: 
ALX Oncology
fast rack
FDA
head and neck cancer
ALX148
gastric cancer
Headline: 
After $105M funding round, ALX Oncology nabs FDA fast-track tag for cancer hopeful
snippet: 

It’s been a good month for ALX Oncology: After getting off a meaty $105 million series C last week, it’s started this week with two fast-track labels for its experimental drug.

Do Not Allow Advertisers to Use My Personal information